Saratov JOURNAL of Medical and Scientific Research

Current state of methodological and decisions for radiation treatment of blood, its components and products

Year: 2014, volume 10 Issue: №4 Pages: 832-838
Heading: radiation medicine Article type: Review
Authors: Gordeev A.V., Naumova L.A., Kharitonov S.V.
Organization: State Scientific Research Center n.a. A.I. Burnasyan — Federal Medical Biophysical Center of Federal Medical Biological Agency

This article presents currently used blood transfusion media — components and blood products, therapeutic effects, reactions and complications of blood transfusion, use of radiation treatment for blood transfusion fluids. There had been discussed in detail the practice of radiation processing of blood components and for the prevention of reaction "graft versus host" and studies of plasma radiation treatment for its infectious safety. There was presented the current state of techniques and technical solutions of radiation treatment of transfusion-transmissible environments. There were also considered an alternative to radiation treatment of blood.

1. Ragimov AA, ed. Transfusion (national leadership). Moscow: Geotar Media, 2012; 1183 p.
2. Afendulov SA, Zhuravlev GU. Transfusion of blood and blood products: a teaching aid. Tambov: TSU Publishing House, 2010; 74 p.
3. Holland PV. Prevention of transfusion-associated graft-ver-sus-host disease. Arch Pathol Lab Med 1989; 113 (3): 285-91
4. Hathaway WE, Githens JH, Blackburn WR, et al. Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children: probable human runt disease. N Engl J Med 1965; 271: 953-954
5. Tomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med 1975; 292: 832-843 and 895-902
6. Anderson КС, Goodnough LT, Sayers M, et al: Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 1991; 77 (10): 2096-2102
7. Chao NJ. Graft-versus-host disease: the viewpoint from the donor T cell. Biol Blood Marrow Transplantation 1997; 3 (1): 1-10
8. Order of Health Ministry on April 2, 2013 N 183n: On approval of rules for the clinical use of blood and (or) its components. RG 2013; № 190
9. Cheung Т, Butson М, Yu PKN. Validation of blood product irradiation doses. Phys Med Biol 2001; 46: 241-244
10. Duguid JKM, Carr R, Jenkins JA, et al. Clinical evaluation of the effects of storage time and irradiation on transfused platelets. Vox Sang 1991; 60: 151-154
11. Goes EG, Borqes JC, Covas DT, et al. Quality control of blood irradiation: determination T cells radiosensitivity to co-balt-60 gamma rays. Transfusion 2006; 46 (1): 34-40
12. Nesis Al. Effect of single irradiated blood transfusion on the body. In: Proc. Irradiation of blood outside the body: Materials Vsesoyuzn.konf. M., 1980; p. 56-62
13. Hansen Е, Bechmann V, Altmeppen J. Intraoperative blood salvage in cancer surgery: safe and effective? Transfus Apheresis Sci 2002; 27 (2): 153-78
14. Hansen E. Cell Salvage in the Presence of Malignancy. Transfusion Alternatives in Transfusion Medicine 2003; 5 (5): 472-477
15. Weisbach V., Eckstein R. Blood Irradiation for Intraoperative Autotransfusion in Cancer Surgery: the View of Transfusion Medicine. Transfusion Medicine and Hemotherapy 2004; 31: 282-285
16. MelanyA. Osby, Sunita Saxena, Shulman Ira A. Safe Handling and Administration of Blood Components: Review of Practical Concepts. Arhives of Patology and Laboratory Medicine 2007; 131 (5): 690-694
17. Transfusion Blood Irradiators Licensed to MDS Nordi-on. htpp://
18. Radiological Devices Advisory Panel April 12, 2012. htpp://www. Committees/CommiteesMeetingMaterials/MedicalDevices/RadiologicalDevicePanelAJCM299255.pdf
19. Filatov FP. Viral safety of blood transfusion. Nature 2005; (3): 3-8
20. Uchaykin VF, Cherednychenko TF, Smirnov AV Hepatology Infectious Diseases: a guide for physicians. Moscow: GEOTAR Media, 2012; 640 p.
21. Zhiburt ЕВ. Benchmarking blanks and Blood Transfusion: A Guide for Physicians. Moscow: RANS, 2009; 364 p.
22. Trofimov VI. Radiation sterilization and disinfection technology: current status and prospects, machinery and equipment. In: Proceedings of the International Symposium "The Role of im-munobiological drugs in modern medicine". Ufa, Russia, 1995; p. 233-238
23. Kusliy AG, Nigmatulin TG, Tal'roze VL, VI Trofimov. Radiation inactivation of viruses in blood plasma, and practical aspects of the fundamental problems. Chemical Physics 2002; 21 (4): 86-95
24. Trofimov VI. Radiation decontamination of blood and plasma derived therefrom protein preparations. Remedium 2003; (5): 62-64
25. Shangareyeva RF. Vliyanie krioradiatsionnoy processing donated blood plasma protein composition of its theme: PhD diss. Ufa, 2002; 129 p.
26. Petz LD, Calhoun L, Yam P, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of fatal case associated with transfusion of blood from a second-degree relative and a survey of predisposing factors. Transfusion 1993; 33: 742
27. Karjakin AV, Terentyeva OA. Validation of ELISA test systems for monitoring viral safety of products manufactured from human blood. Problems of Hematology and Blood Transfusion 2001; (3): 52-53
28. Shuvalova ЕР. Infectious diseases: textbook. Moscow: Meditsina, 2001; 640 p.
29. Ragimov A.A. Molecular Hemotransfusion. Bulletin of the blood service in Russia 2013; (2): 10-19
30. Zhiburt ЕВ. Terms of plasma transfusion: Guidelines for doctors. Moscow: Meditsina, 2008; 240 p.
31. Chechetkin AV, Director RosNIIGT FMBA of Russia. From a scientific idea to production substitutes. Who's Who in Medicine 2014; 66 (2): 57
32. Bertolini Josef, Neil Goss, John Curling. Production of Plasma Proteins for Therapeutic Use.Hoboken, N. J.: John Wley & Sons, 2013; 512 p.
33. Savilova AM, Trofimov DY, Aleseev LP, Haitov RM. DNA vaccines: current status and prospects. Immunologiya 2007; (2): 114-123
34. Giarrantana МС, Rougard Н, Dumont A, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood: Published online. September 1, 2011, doi: 10.1182/ blood-2011-06-362038
35. Takeoka S. Developmental trend of Artificial Blood. JMAJ 2005; 48 (3): 135-139.

2014_04-01_832-838.pdf329.56 KB

No votes yet